Skip to main content

UBS Group AG

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in CRVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,917,972
+$1,688,235 QoQ
Shares Held
396,116
+37.0% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CRVS ranks #138 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,917,972 396,116
2026-03-31 $4,229,737 289,114
2025-12-31 $1,632,445 212,006
2025-09-30 $1,194,484 162,074
2025-06-30 $358,856 89,714
2025-03-31 $115,732 36,394
2024-12-31 $278,782 52,109
2024-09-30 $82,795 15,681
2024-06-30 $23,660 13,000
2024-03-31 $8,328 4,679
2023-12-31 $11,792 6,700
2023-09-30 $9,782 6,700
2023-06-30 $15,343 6,700
2023-03-31 $10,022 11,014
2022-12-31 $3,995 4,700
2022-09-30 $18,555 22,656
2022-06-30 $22,344 22,571
2022-03-31 $23,135 14,107
2021-12-31 $22,340 9,270
2021-09-30 $14,520 3,000
2021-06-30 $8,010 3,000
2021-03-31 $9,240 3,000
2020-12-31 $35,753 10,043
2020-09-30 $17,255 4,303
2020-06-30 $1,955 719
2020-03-31 $5,941 2,816